Ask Warren

GC Medical Science

142280 · KOSDAQ · ₩142280 · 녹십자엠에스

₩3,085▼ ₩75 (2.37%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩27B₩24B₩25B₩26B₩30B₩26B₩28B₩27B
Cost of sales₩24B₩20B₩22B₩23B₩26B₩23B₩23B₩23B
Gross profit₩3.5B₩3.2B₩3B₩3.9B₩4.4B₩3.8B₩4.5B₩3.5B
Operating income₩743M₩292M₩390M₩944M₩1.1B₩495M₩971M₩931M
Net income−₩4B₩221M₩333M₩1.4B₩2.4B−₩727M₩2.1B₩179M
Net income to shareholders−₩4B₩145M₩369M₩1.4B₩2.6B−₩662M₩2.4B₩136M

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩97B₩91B₩91B₩97B₩105B₩95B₩88B₩89B
Current assets₩47B₩42B₩41B₩47B₩54B₩46B₩39B₩41B
Cash and equivalents₩261M₩956M₩373M₩618M₩272M₩1.7B₩678M₩1B
Total liabilities₩41B₩45B₩44B₩50B₩59B₩53B₩45B₩48B
Current liabilities₩32B₩36B₩35B₩42B₩51B₩45B₩37B₩40B
Borrowings₩8.7B₩13B₩11B₩15B₩18B₩0₩0₩19B
Total equity₩56B₩47B₩46B₩47B₩45B₩43B₩43B₩41B
Shareholders' equity₩54B₩45B₩44B₩45B₩43B₩41B₩41B₩39B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩715M−₩161M₩5B₩4.2B−₩2.1B₩20M−₩814M₩2.7B
Capital spending₩255M₩484M₩405M−₩121M₩3B₩1.4B₩114M₩1.3B
Free cash flow−₩970M−₩645M₩4.6B₩4.1B−₩5.1B−₩1.4B−₩928M₩1.4B

Consolidated where available. Amounts in won.

Also known as: GC Medical Science / 녹십자엠에스 / 142280 / KRX:142280

Source: KRX statistical information